Announcements Trials
Browse Landscape

Phase

Phase NA 3

Status

Completed 2Unknown 1

Sponsor Class

OTHER 3

Study Type

Interventional 3

Sponsor

Conditions

Tuberous Sclerosis 3Epilepsy 1Child Development Disorders, Pervasive 1Autistic Disorder 1

Interventions

Cyclophosphamide 2067Radiotherapy 1990Cisplatin 1856Carboplatin 1560Gemcitabine 1454Paclitaxel 1320Bevacizumab 1320pembrolizumab 1238Docetaxel 1227Oxaliplatin 1184Capecitabine 1178Fluorouracil 1083Dexamethasone 979Magnetic Resonance Spectroscopy 971Nivolumab 936Rituximab 929Drug Therapy 915Surveys and Questionnaires 899Doxorubicin 845Etoposide 843Radiosurgery 816Blood Specimen Collection 816Irinotecan 784Cytarabine 743fludarabine 726Leucovorin 684Surgical Procedures, Operative 640Lenalidomide 618Biopsy 594fludarabine phosphate 569

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
OTHER × Activator Appliances × Clear all
NCT04698538 2024-10-30

TRAIN

University of California, Los Angeles

Phase NA Completed
54 enrolled

Tuberous Sclerosis

NCT03422367 2020-11-06

JETS

University of California, Los Angeles

Phase NA Unknown
64 enrolled

Autistic Disorder, Child Development Disorders, Pervasive, Epilepsy, Tuberous Sclerosis

NCT02687633 2018-05-02

Early Behavioral Intervention to Improve Social Communication Function in Infants With Tuberous Sclerosis Complex

University of California, Los Angeles

Phase NA Completed
8 enrolled

Tuberous Sclerosis

Data powered by HemOnc (CC BY 4.0) Colophon âš¡